a multicenter , open trial was designed to examine the efficacy and safety of semi-synthetic human insulin ( sshi ; novolin r and novolin l , squibb-novo ) in patients with insulin-dependent diabetes mellitus who were transferred from other commercially-available insulins .
C0795635
human insulin
C0011854
insulin-dependent diabetes mellitus